Prostate News Archive
03-Jan-2009
Cough medicine ingredient may treat prostate cancer (Reuters via Yahoo! News)
Noscapine, a natural substance found in cough medicine, may prove useful in treating advanced prostate cancer, according to studies in mice. FDA Approves Drug For Patients With Advanced Prostate Cancer (Medical News Today)
The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advanced prostate cancer. It belongs to a class of agents called gonadotropin releasing hormone (GnRH) receptor inhibitors. HMC to resume prostate cancer screening (The Peninsula)
Doha: The Hamad Medical Corporation (HMC) will soon resume prostate cancer screening, which was put on hold during the holy month of Ramadan. Why prostate cancer patients fail hormone deprivation therapy (News-Medical-Net)
The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. Family history of prostate cancer does not affect some treatment outcomes (EurekAlert!)
( American Society for Therapeutic Radiology and Oncology ) In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy, also called seed implants, and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, ...
Back to Prostate News Archive
